These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18670387)

  • 1. Intraoperative coagulation was more interfered by HES 200/0.5 than normal saline in off-pump coronary artery bypass surgery.
    Yen TS; Chan KC; Cheng YJ
    J Cardiovasc Surg (Torino); 2008 Oct; 49(5):679-84. PubMed ID: 18670387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hydroxyethyl starch 130/0.4 on blood loss and coagulation in patients with recent exposure to dual antiplatelet therapy undergoing off-pump coronary artery bypass graft surgery.
    Lee JS; Ahn SW; Song JW; Shim JK; Yoo KJ; Kwak YL
    Circ J; 2011; 75(10):2397-402. PubMed ID: 21817820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized prospective analysis of alteration of hemostatic function in patients receiving tranexamic acid and hydroxyethyl starch (130/0.4) undergoing off pump coronary artery bypass surgery.
    Chakravarthy M; Muniraj G; Patil S; Suryaprakash S; Mitra S; Shivalingappa B
    Ann Card Anaesth; 2012; 15(2):105-10. PubMed ID: 22508200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of 6 % hydroxyethyl starch (HES) 130/0.4 on the correlation between standard laboratory tests and thromboelastography (TEG®) after cardiopulmonary bypass.
    Hans GA; Hartstein G; Roediger L; Hubert B; Peters P; Senard M
    Thromb Res; 2015 May; 135(5):984-9. PubMed ID: 25769493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New 6% hydroxyethyl starch 130/0.4 does not increase blood loss during major abdominal surgery - a randomized, controlled trial.
    Hung MH; Zou C; Lin FS; Lin CJ; Chan KC; Chen Y
    J Formos Med Assoc; 2014 Jul; 113(7):429-35. PubMed ID: 24961184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of a balanced crystalloid-based and a saline-based tetrastarch solution on canine whole blood coagulation and platelet function.
    Reuteler A; Axiak-Flammer S; Howard J; Adamik KN
    J Vet Emerg Crit Care (San Antonio); 2017 Jan; 27(1):23-34. PubMed ID: 27926787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vitro comparison of the effects of voluven (6% hydroxyethyl starch 130/0.4) and hespan (6% hydroxyethyl starch 670/0.75) on measures of blood coagulation in canine blood.
    Griego-Valles M; Buriko Y; Prittie JE; Fox PR
    J Vet Emerg Crit Care (San Antonio); 2017 Jan; 27(1):44-51. PubMed ID: 27712013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy.
    Boldt J; Suttner S; Brosch C; Lehmann A; Röhm K; Mengistu A
    Anesth Analg; 2009 Dec; 109(6):1752-62. PubMed ID: 19923501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune and inflammatory role of hydroxyethyl starch 130/0.4 and fluid gelatin in patients undergoing coronary surgery.
    Öztürk T; Onur E; Cerrahoğlu M; Çalgan M; Nizamoglu F; Çivi M
    Cytokine; 2015 Jul; 74(1):69-75. PubMed ID: 25458745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Third-Generation Hydroxyethyl Starch Causes Dose-Dependent Coagulopathy in Patients Undergoing Off-Pump Coronary Artery Bypass with Continuation of Preoperative Aspirin.
    Kusumoto GO; Higashi M; Shigematsu K; Yamaura K
    Heart Surg Forum; 2021 Sep; 24(5):E949-E854. PubMed ID: 34623243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 6% hydroxyethyl starch 130/0.4 on postoperative blood loss and kidney injury in off-pump coronary arterial bypass grafting: A retrospective study.
    Min JJ; Cho HS; Jeon S; Lee JH; Lee JJ; Lee YT
    Medicine (Baltimore); 2017 May; 96(18):e6801. PubMed ID: 28471979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients.
    Haisch G; Boldt J; Krebs C; Suttner S; Lehmann A; Isgro F
    J Cardiothorac Vasc Anesth; 2001 Jun; 15(3):316-21. PubMed ID: 11426361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses.
    Kasper SM; Meinert P; Kampe S; Görg C; Geisen C; Mehlhorn U; Diefenbach C
    Anesthesiology; 2003 Jul; 99(1):42-7. PubMed ID: 12826840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of a waxy maize and a potato starch-based balanced hydroxyethyl starch for priming in patients undergoing coronary artery bypass grafting.
    Sethi BS; Chauhan S; Bisoi AK; Kapoor PM; Kiran U; Rajput RS
    J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):690-7. PubMed ID: 24144628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of balanced HES 130/0.42 during complex cardiac surgery; effect on blood coagulation and fluid balance: a randomized controlled trial.
    Schramko A; Suojaranta-Ylinen R; Niemi T; Pesonen E; Kuitunen A; Raivio P; Salmenperä M
    Perfusion; 2015 Apr; 30(3):224-32. PubMed ID: 24947459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin anticoagulation in patients undergoing off-pump and on-pump coronary bypass surgery.
    Tanaka KA; Thourani VH; Williams WH; Duke PG; Levy JH; Guyton RA; Puskas JD
    J Anesth; 2007; 21(3):297-303. PubMed ID: 17680178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery.
    Haisch G; Boldt J; Krebs C; Kumle B; Suttner S; Schulz A
    Anesth Analg; 2001 Mar; 92(3):565-71. PubMed ID: 11226079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of intraoperative 6% balanced hydroxyethyl starch (130/0.4) during cardiac surgery on transfusion requirements.
    Hans GA; Ledoux D; Roediger L; Hubert MB; Koch JN; Senard M
    J Cardiothorac Vasc Anesth; 2015 Apr; 29(2):328-32. PubMed ID: 25440623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the carrier solution for hydroxyethyl starch on platelet aggregation and clot formation.
    Schaden E; Wetzel L; Kozek-Langenecker S; Thaler U; Scharbert G
    Br J Anaesth; 2012 Oct; 109(4):572-7. PubMed ID: 22791802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, randomized comparison of thromboelastographic coagulation profile in patients receiving lactated Ringer's solution, 6% hetastarch in a balanced-saline vehicle, or 6% hetastarch in saline during major surgery.
    Martin G; Bennett-Guerrero E; Wakeling H; Mythen MG; el-Moalem H; Robertson K; Kucmeroski D; Gan TJ
    J Cardiothorac Vasc Anesth; 2002 Aug; 16(4):441-6. PubMed ID: 12154422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.